What is the recommended dose and treatment regimen of hydrocortisone for a patient presenting with anaphylaxis or a severe allergic reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydrocortisone Dosing for Anaphylaxis

Hydrocortisone should be administered at 200 mg IV or IM for adults (>12 years), 100 mg for children 6-12 years, 50 mg for children 6 months to 6 years, and 25 mg for infants <6 months, but only as adjunctive therapy after epinephrine—it provides no acute benefit and should never delay or replace epinephrine administration. 1, 2

Critical First-Line Treatment

  • Epinephrine 0.3-0.5 mg IM (1:1000) into the anterolateral thigh is the only first-line treatment for anaphylaxis and must be given immediately. 3, 4, 5, 2
  • Repeat epinephrine every 5-15 minutes as needed if symptoms persist or progress. 5, 2
  • Do not delay epinephrine administration to give corticosteroids or antihistamines. 3, 5

Hydrocortisone Dosing Regimen

Age-based dosing (IM or IV):

  • Adults and children >12 years: 200 mg 1, 2
  • Children 6-12 years: 100 mg 1, 2
  • Children 6 months to 6 years: 50 mg 1, 2
  • Infants <6 months: 25 mg 1, 2

Alternative corticosteroid regimens:

  • Methylprednisolone 1-2 mg/kg IV every 6 hours (typically 40 mg IV every 6 hours for a 70 kg adult) 2, 6
  • The FDA label indicates hydrocortisone can be given as 100-500 mg IV initially, repeated at 2,4, or 6-hour intervals based on patient response. 7

Role and Limitations of Corticosteroids

  • Corticosteroids provide no acute benefit in anaphylaxis management—their anti-inflammatory effects do not appear for 6-12 hours after administration. 2, 6
  • They are given to potentially prevent biphasic reactions (which occur in up to 20% of cases) and protracted anaphylaxis, though evidence for this is weak. 3, 2, 6
  • The 2020 Joint Task Force Practice Parameter suggests against administering glucocorticoids as an intervention to prevent biphasic anaphylaxis (conditional recommendation, very low certainty of evidence). 3
  • Despite limited evidence, corticosteroids may be considered as secondary treatment, particularly for patients with severe or prolonged anaphylaxis, history of asthma, or those requiring multiple epinephrine doses. 3, 2

Complete Acute Management Algorithm

Immediate actions:

  1. Administer epinephrine 0.3-0.5 mg IM (anterolateral thigh) 4, 5, 2
  2. Position patient supine with legs elevated (unless respiratory distress) 2
  3. Establish IV access and give crystalloid bolus (500-1000 mL adults, 20 mL/kg children) 2
  4. Provide supplemental oxygen and monitor vital signs 2

Adjunctive medications (after epinephrine):

  • H1-antihistamine: Diphenhydramine 25-50 mg IV/IM (1-2 mg/kg) 2, 6
  • H2-antihistamine: Ranitidine 50 mg IV or famotidine 20 mg IV (H1+H2 combination superior to H1 alone) 2, 6
  • Corticosteroid: Hydrocortisone per age-based dosing above OR methylprednisolone 1-2 mg/kg IV 1, 2, 6

For persistent bronchospasm:

  • Albuterol nebulization 2.5-5 mg in 3 mL saline (after epinephrine) 5, 2

For refractory hypotension:

  • Repeat epinephrine every 5-15 minutes 5, 2
  • Consider epinephrine IV infusion 5-15 mcg/min if unresponsive to IM doses 2
  • Aggressive fluid resuscitation (1-2 L crystalloid bolus for adults) 2

Special Population: Patients on Beta-Blockers

  • If anaphylaxis is refractory to multiple epinephrine doses and adequate fluids, administer glucagon 1-5 mg IV over 5 minutes (20-30 mcg/kg for children, maximum 1 mg), followed by continuous infusion at 5-15 mcg/min. 5, 2, 6
  • Glucagon is reserved exclusively for beta-blocker patients with refractory anaphylaxis—it should never replace or delay epinephrine. 2

Observation and Discharge Planning

  • Observe all patients for at least 4-6 hours after symptom resolution, with longer observation (up to 24 hours) for severe reactions, those requiring multiple epinephrine doses, or patients with risk factors for biphasic reactions. 3, 2, 6
  • Risk factors for biphasic anaphylaxis include severe initial presentation, need for >1 dose of epinephrine, wide pulse pressure, unknown trigger, and drug trigger in children. 3

Discharge medications:

  • Prednisone 0.5-1 mg/kg daily (maximum 60-80 mg) for 2-3 days 2, 6
  • Two epinephrine auto-injectors with hands-on training 2, 6
  • H1-antihistamine and H2-antihistamine for 2-3 days 2
  • Written anaphylaxis action plan 2
  • Referral to allergist within 1-2 weeks 3, 2

Critical Pitfalls to Avoid

  • Never delay or withhold epinephrine to give antihistamines or corticosteroids—epinephrine is the only medication that treats acute anaphylaxis. 3, 5, 2
  • Do not discharge patients prematurely, especially those with airway involvement or severe reactions. 3, 2
  • Do not rely on corticosteroids to prevent biphasic reactions—extended observation is more important. 3
  • Be aware that rare cases of anaphylaxis to hydrocortisone itself have been reported, though this is extremely uncommon. 8, 9

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

clinical practice guideline: immunotherapy for inhalant allergy.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2024

Guideline

Anaphylaxis Management in Patients on Chronic Steroid Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hydrocortisone anaphylaxis: a new case report.

Pharmaceutisch weekblad. Scientific edition, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.